Study of Pts With Philadelphia Chromosome-Pos ALL With Comb of Ibrutinib, Dasatinib, and Prednisone

NCT02815059 · clinicaltrials.gov ↗

PHASE1

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Termination of Investigator Initiated Studies using Ibrutinib

Conditions

Acute Lymphoblastic Leukemia

Interventions

DRUG: Ibrutinib
DRUG: Dasatinib
DRUG: Prednisone

Sponsor

University of Utah

Collaborators

[object Object]